CaƱete, Baby Girl .
HRN: 27-72-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
09/07/2025
09/13/2025
IV
14.5mg
Q24 Hours
NAMF (PROM)
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines